Skip to content

Afsnit 334: Derfor har Novos CEO travlt

August 19, 2026 · 30 min

Show notes

Status på Novo Nordisk efter et år med CEO Mike Doustdar, Zealand Pharma-regnskab, shortsalg i C25-aktier, prisen på A.P. Møller-Mærsk samt meget mere i ugens afsnit.

Læs Pers artikel om Novo Nordisk: https://www.nordnet.dk/blog/1-ar-som-ceo-novo

00:00 Intro
00:56 Danske regnskaber (Royal Unibrew, Coloplast, Rockwool, Carlsberg)
06:47 Zealand Pharma
12:26 A.P. Møller-Mærsk
20:55 Novo Nordisk - status


Besøg Pers Univers her
Følg Per Hansen på X
Følg Per Hansen på LinkedIn

All episodes of Investeringspodcasten

Settings

Display

Language

Decides which stations you see first on the home page.

History

Recently played stations and episodes and your latest searches are only stored in this browser.

Notifications

A short notice when a podcast you follow has a new episode. Turn off single podcasts with the bell on their page.

Account

Save favorites – in the app and on the website.

Keyboard shortcuts

/
Open search
Space
Play or pause
← →
In the player: back 15 s, forward 30 s (episodes) · in a row: next tile
↑ ↓
In a row: target within the tile
Home / End
In a row: first or last tile
Esc
Close window or menu
?
This overview
Now playing

Go to station page

Play next

    Add episodes with “Play next” – they play after the current episode.